MLEC
Moolec Science SA
NASDAQ · Healthcare · Biotechnology · LU
$1.54
−8.63%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.62
From 52W high−91.02%
Volume28820.00
Market cap$3.19M
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataOct 19, 2026
Open
$1.62
From 52W high
−91.02%
Volume
28820.00
Market cap
$3.19M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.3x
P/E (TTM)
—
RSI (14)
17.6
MomentumView details →
1D Return
−8.63%
YTD Return
−57.46%
SummaryUpdated Jun 1, 2025
Moolec Science SA (NASDAQ:MLEC) is a Luxembourg-based biotechnology company founded in 2008 that specializes in producing animal proteins in plants through a technology called Molecular Farming. The company went public in March 2021 and operates across the United States, Europe, and South America. Moolec represents a disruptive approach in the alternative protein landscape, leveraging the natural efficiency of crops like soybeans and peas to produce traditionally animal-derived proteins through genetic engineering techniques.
Similar companies
Latest newsMore news →
No recent news for MLEC.